5,?8,?11-?Trioxa-?2-?azatridecanoic acid, 13-?amino-?, (1α,?8α,?9β)?-?bicyclo[6.1.0]?non-?4-?yn-?9-?ylmethyl ester manufacturers
- endo BCN-PEG3-amine
-
- $0.00 / 50mg
-
2025-06-07
- CAS:1883512-27-3
- Min. Order: 50mg
- Purity: >95.00%
- Supply Ability: 250mg
|
| | 5,?8,?11-?Trioxa-?2-?azatridecanoic acid, 13-?amino-?, (1α,?8α,?9β)?-?bicyclo[6.1.0]?non-?4-?yn-?9-?ylmethyl ester Basic information |
| Product Name: | 5,?8,?11-?Trioxa-?2-?azatridecanoic acid, 13-?amino-?, (1α,?8α,?9β)?-?bicyclo[6.1.0]?non-?4-?yn-?9-?ylmethyl ester | | Synonyms: | BCN-PEG3-AMINE (ENDO);endo BCN-PEG3-NH2;BCN-endo-PEG3-NH2;endo-BCN-PEG3-amine;5,8,11-Trioxa-2-azatridecanoic acid, 13-amino-, (1α,8α,9β)-bicyclo[6.1.0]non-4-yn-9-ylmethyl ester | | CAS: | 1883512-27-3 | | MF: | C19H32N2O5 | | MW: | 368.47 | | EINECS: | | | Product Categories: | SiChem | | Mol File: | 1883512-27-3.mol | ![5,?8,?11-?Trioxa-?2-?azatridecanoic acid, 13-?amino-?, (1α,?8α,?9β)?-?bicyclo[6.1.0]?non-?4-?yn-?9-?ylmethyl ester Structure](CAS/20211123/GIF/1883512-27-3.gif) |
| | 5,?8,?11-?Trioxa-?2-?azatridecanoic acid, 13-?amino-?, (1α,?8α,?9β)?-?bicyclo[6.1.0]?non-?4-?yn-?9-?ylmethyl ester Chemical Properties |
| Boiling point | 519.6±40.0 °C(Predicted) | | density | 1.14±0.1 g/cm3(Predicted) | | storage temp. | -20°C, sealed storage, away from moisture and light | | form | Oil | | pka | 12.05±0.46(Predicted) | | color | Light yellow to yellow |
| | 5,?8,?11-?Trioxa-?2-?azatridecanoic acid, 13-?amino-?, (1α,?8α,?9β)?-?bicyclo[6.1.0]?non-?4-?yn-?9-?ylmethyl ester Usage And Synthesis |
| Description | endo-BCN-PEG3-amine is a click chemistry linker containing a BCN and an amine group. The BCN group can react with azide-tagged biomolecules under mile condition. The amino group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. | | Uses | endo-BCN-PEG3-NH2 is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. endo-BCN-PEG3-NH2 is a click chemistry reagent, it contains a BCN group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. | | IC 50 | PEGs | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| | 5,?8,?11-?Trioxa-?2-?azatridecanoic acid, 13-?amino-?, (1α,?8α,?9β)?-?bicyclo[6.1.0]?non-?4-?yn-?9-?ylmethyl ester Preparation Products And Raw materials |
|